Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis

Oncology

Volumn 81, Issue 1, 2011, Pages 39-44

  Wakuta, Akiko ^a   Nouso, Kazuhiro ^a   Kariyama, Kazuya ^a,b   Nishimura, Mamoru ^a   Kishida, Masayuki ^a   Wada, Nozomu ^a   Mizushima, Takaaki ^a   Higashi, Toshihiro ^a   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama Citizens Hospital   (Japan)

Author keywords

Decompensated cirrhosis; Hepatocellular carcinoma; Radiofrequency ablation

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN; BIOLOGICAL MARKER; PROTHROMBIN; TUMOR MARKER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CANCER PATIENT; CANCER SURVIVAL; DECOMPENSATED LIVER CIRRHOSIS; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMATOTHORAX; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT MONITORING; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052581782     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000331411     Document Type: Article

References (21)

1. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E: Hepatocellular carcinoma: Recent trends in Japan. Gastroenterology 2004; 127:S17-S26. (Pubitemid 39423366)
2. Okita K: Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 2006; 45: 229-233.
3. Chung H, Ueda T, Kudo M: Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 2010; 53: 39-43.
4. Nordenstedt H, White DL, El-Serag HB: The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010; 42:S206-S214.
5. Takuma Y, Nouso K: Nonalcoholic steatohepatitis- associated hepatocellular carcinoma: Our case series and literature review. World J Gastroenterol 2010; 16: 1436-1441.
6. Gao C, Yao SK: Diabetes mellitus: A 'true' independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int 2009; 8: 465-473.
7. Kudo M: Early detection and curative treatment of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol 2005; 3:S144-S148. (Pubitemid 41427748)
8. Takayasu K, Muramatsu Y, Mizuguchi Y, Ojima H: CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology 2007; 72(suppl 1): 83-91. (Pubitemid 350256670)
9. Kudo M: Hepatocellular carcinoma 2009 and beyond: From the surveillance to molecular targeted therapy. Oncology 2008; 75 (suppl 1):1-12.
10. Kudo M: Real practice of hepatocellular carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress. Oncology 2010; 78(suppl 1): 180-188.
11. Izumi N: Diagnostic and treatment algorithm of the Japanese society of hepatology: A consensus-based practice guideline. Oncology 2010; 78(suppl 1): 78-86.
12. Kokudo N, Makuuchi M: Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: The J-HCC guidelines. J Gastroenterol 2009; 44: 119-121.
13. Kudo M, Okanoue T: Management of hepatocellular carcinoma in Japan: Consensusbased clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72(suppl 1): 2-15. (Pubitemid 350256660)
14. Minami Y, Kudo M: Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol 2010; 2: 417-424.
15. Kudo M: Radiofrequency ablation for hepatocellular carcinoma: Updated review in 2010. Oncology 2010; 78(suppl 1): 113-124.
16. Kuroda H, Kasai K, Kakisaka K, Yasumi Y, Kataoka K, Ushio A, Miyamoto Y, Sawara K, Oikawa K, Kondo K, Miura Y, Endo R, Takikawa Y, Suzuki K: Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma. Hepatol Res 2010; 40: 550-554.
17. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
18. Izumi N: Recent advances of radiofrequency ablation for early hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26: 115-122.
19. Nouso K, Ito Y, Kuwaki K, Kobayashi Y, Nakamura S, Ohashi Y, Yamamoto K: Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. Br J Cancer 2008; 98: 1161-1165. (Pubitemid 351481668)
20. Boin IF, Leonardi MI, Pinto AO, Leme RS, Udo E, Stucchi RS, Soares EC, Leonardi LS: Liver transplant recipients mortality on the waiting list: Long-term comparison to Child- Pugh classification and MELD. Transplant Proc 2004; 36: 920-922. (Pubitemid 38766223)
21. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M: Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005; 12: 16-22. (Pubitemid 40378835)